Skip to Content


HOUSE DOCKET, NO. 1737         FILED ON: 1/17/2013

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 989

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Theodore C. Speliotis

_______________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
              Court assembled:

              The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to Lyme Disease treatment coverage.

_______________

PETITION OF:

 

Name:

District/Address:

Theodore C. Speliotis

13th Essex

David Paul Linsky

5th Middlesex

Daniel A. Wolf

Cape and Islands

Timothy R. Madden

Barnstable, Dukes and Nantucket

Sarah K. Peake

4th Barnstable

William Smitty Pignatelli

4th Berkshire

Bradford Hill

4th Essex

Anne M. Gobi

5th Worcester

Brian R. Mannal

2nd Barnstable

Todd M. Smola

1st Hampden

Ruth B. Balser

12th Middlesex

Kay Khan

11th Middlesex

Angelo J. Puppolo, Jr.

12th Hampden

Josh S. Cutler

6th Plymouth

Cleon H. Turner

1st Barnstable

Eileen M. Donoghue

First Middlesex

William N. Brownsberger

Second Suffolk and Middlesex

Chris Walsh

6th Middlesex

David M. Rogers

24th Middlesex

Mary S. Keefe

15th Worcester

John V. Fernandes

10th Worcester

Christopher M. Markey

9th Bristol

John J. Lawn, Jr.

10th Middlesex

Jonathan D. Zlotnik

2nd Worcester

Denise C. Garlick

13th Norfolk

Stephen L. DiNatale

3rd Worcester

Paul K. Frost

7th Worcester

Thomas M. McGee

Third Essex

Ellen Story

3rd Hampshire

Michael J. Rodrigues

First Bristol and Plymouth

James E. Timilty

Bristol and Norfolk

Robert F. Fennell

10th Essex

Sheila C. Harrington

1st Middlesex

Tom Sannicandro

7th Middlesex

Thomas M. Stanley

9th Middlesex

Marjorie C. Decker

25th Middlesex

Sean Garballey

23rd Middlesex


HOUSE DOCKET, NO. 1737        FILED ON: 1/17/2013

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 989

By Mr. Speliotis of Danvers, a petition (accompanied by bill, House, No. 989) of Theodore C. Speliotis and others relative to Lyme disease treatment coverage.  Financial Services. 

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 329 OF 2011-2012.]


The Commonwealth of Massachusetts
 

_______________

In the Year Two Thousand Thirteen

_______________

 

An Act relative to Lyme Disease treatment coverage.
 

              Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

              SECTION 1. Chapter 111, as appearing in the 2010 Official Edition, is hereby amended by inserting, after section 218, the following new sections:

              SECTION 219. Every individual or group hospital or medical expense insurance policy or individual or group hospital or medical services plan contract delivered, issued for delivery or renewed in this state on or after January 1, 2010, shall provide for Lyme disease treatment.

              SECTION 220. Every individual or group hospital or medical expense insurance policy or individual or group hospital or medical services plan contract delivered, issued for delivery or renewed in this state on or after January 1, 2010, shall provide coverage for diagnostic testing and long-term antibiotic treatment of chronic Lyme disease when determined to be medically necessary and ordered by a physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results and response to treatment. Treatment otherwise eligible for benefits pursuant to this section shall not be denied solely because such treatment may be characterized as unproven, experimental, or investigational in nature. Provided, however, this section shall not apply to insurance coverage providing benefits for:

              Hospital confinement indemnity;

              Disability income;

              Accident only;

              Long-term care;

              Medicare supplement;

              Limited benefit health;

              Specified disease indemnity;

              Sickness or bodily injury or death by accident or both; and

              Other limited benefit policies.

              Section 221. Subscribers to any health maintenance organization plan shall be afforded coverage under that plan on or after January 1, 2010 for diagnostic testing and long term antibiotic treatment of chronic Lyme disease when determined to be medically necessary and ordered by a physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results and response to treatment. Treatment otherwise eligible for benefits pursuant to this section shall not be denied solely because such treatment may be characterized as unproven, experimental, or investigational in nature.              

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Error